Related Experiment Videos

Soluble fibrinogen--fibrin complexes in intrauterine growth retardation

Insights

Pregnant women with intrauterine growth retardation showed higher soluble fibrinogen-fibrin complex levels. This may indicate increased placental coagulation, suggesting potential for antenatal diagnosis using coagulation tests.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatology

Background:

  • Intrauterine growth retardation (IUGR) is a significant complication of pregnancy.
  • Placental insufficiency and altered coagulation are implicated in IUGR.
  • Soluble fibrinogen-fibrin complexes (SFFC) are markers of coagulation activation.

Purpose of the Study:

  • To investigate SFFC levels in pregnancies with IUGR.
  • To explore the association between SFFC and placental coagulation in IUGR.
  • To assess the potential diagnostic utility of coagulation markers for IUGR.

Main Methods:

  • Plasma samples were collected from pregnant women with IUGR and normal pregnancies.
  • Soluble fibrinogen-fibrin complex levels were measured.
  • Histological examination of placental tissue was performed.

Main Results:

  • Significantly higher SFFC levels were observed in women with IUGR compared to normal pregnancies.
  • Findings suggest increased local intravascular coagulation within the placenta in IUGR pregnancies.
  • Histological evidence supported increased placental coagulation in complicated pregnancies.

Conclusions:

  • Elevated SFFC levels may serve as an indicator of placental coagulation activation in IUGR.
  • Sensitive methods for coagulation, fibrinolysis, and platelet function could aid in antenatal IUGR diagnosis.
  • Further research into coagulation markers for IUGR is warranted.

Related Concept Videos